Specialty Pharmacy

Top news of the day from across the healthcare landscape.

Top news of the week from Specialty Pharmacy Times.

The FDA a stop to Celgene’s REVOLVE trial and extension trial for GED-0301 (mongersen), an oral compound currently not approved for any uses.

Early detection is crucial for breast cancer survival.

The Partnership for Accelerating Cancer Therapies seeks to standardize biomarkers for cancer immunotherapy drugs.

Moderately effective vaccine could boost efforts to cure HIV.

Allergy medication may cause remyelination in humans with multiple sclerosis.

Top news from across the healthcare landscape.

FDA says ‘yes’ to axicabtagene ciloleucel (Yescarta), a gene therapy for lymphoma.

During a time when cancer rates are declining overall, obesity-linked disease is increasing.

Investigational multiple sclerosis drug may also treat inflammatory bowel disease.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the negative impact of a slow turnaround on patient care.

Patients with Ewing sarcoma typically receive a 5-drug cocktail that can result in nerve damage.

Veterans may be up to 5 times more likely to have hepatitis C than the general population.

Top news of the day from across the healthcare landscape.

Approximately 300,000 pharmacists are eligible to vaccinate adult patients in the pharmacy.

The most impactful of the FDA designations, this status may be applied to drugs used to treat serious or life-threatening conditions.

FDA grants nivolumab (Opdivo) its seventh priority review designation.

Approximately 10% of the HIV population will die from lung cancer.

Patients undergoing chemotherapy can use Emend with other antiemetic medicines to prevent chemotherapy-related nausea and vomiting.

Patients with cancer were less likely to receive standard drugs and interventions for heart attack than patients without cancer.

Top news of the day from across the healthcare landscape.

Individuals with an undetectable HIV viral load are at effectively no risk of transmitting the virus.

The monoclonal antibody dupilumab may be effective treating active moderate-to-severe eosinophilic esophagitis.

Independent community pharmacies expand the services they offer patients.

Leaders in specialty pharmacy must work to improve employee engagement in order to boost the customer experience.

Many patients with rheumatoid arthritis feel their employers do not understand their condition.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.